| Director, Biostatistics | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Director, Purification Development, Emerging Modalities | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Senior Director, Head of PV Science | Alnylam Pharmaceuticals | Philadelphia, United States | 2026-07-17 |
| Director, Peptide Process Development | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Biostatistics | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Senior Director, Biocatalysis | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Supply Network Strategy Operations | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, CMC Technology Delivery | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Regional Business Director, TTR - River Valley (MI, OH, KY, TN) | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Regional Business Director, TTR - Gulf Coast (FL, AL, MS, LA, AR) | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| MSL Regional Field Director | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Senior Director Biostatistics Head of Statistical Innovation & Methodology | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Lab Computing and Facilities Technology | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Laboratory Informatics Platforms | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Program Management | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Multimodal Discovery Platform | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Statistical Programming | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Director, US Patient Services Operations | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Sr. Director, National Patient Field Teams Lead | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Oncology Algorithm & Data Products | Natera | United States | 2026-07-17 |
| Associate Director, Laboratory Operations- TiH | Natera | Austin, United States | 2026-07-17 |
| Senior Director, ECD Product Strategy | Natera | United States | 2026-07-17 |
| Associate Director, Laboratory Operations | Natera | San Carlos, United States | 2026-07-17 |
| Director Patient Advocacy, Oncology | Natera | United States | 2026-07-17 |
| Director, Biopharma & Consortia Engagement | Natera | United States | 2026-07-17 |
| Director, Field Translational Science - Oncology | Natera | United States | 2026-07-17 |
| Laboratory Director | Natera | San Carlos, United States | 2026-07-17 |
| Laboratory Director (ABMG) | Natera | San Carlos, United States | 2026-07-17 |
| Associate Laboratory Director | Natera | San Carlos, United States | 2026-07-17 |
| Associate Director, Speaker Programs | Natera | United States | 2026-07-17 |
| Director of National Accounts, Oncology (NE) | Natera | Newark, United States | 2026-07-17 |
| Regional Director, Strategic Accounts | Natera | United States | 2026-07-17 |
| Associate Director, Strategic Program Management | Natera | United States | 2026-07-17 |
| Senior Director, Technical Operations | Oxford Biomedica | United Kingdom | 2026-07-17 |
| Directeur des Affaires Corporatives Canada Corporate Affairs Director | Grifols | Mississauga, Canada | 2026-07-17 |
| SVP, Strategic Partnerships | Evotec | Germany | 2026-07-17 |
| Senior Director, Head of Transformation Operations US | Lonza | United States | 2026-07-17 |
| Senior Director, Head of MSAT - Houston | Lonza | Houston, United States | 2026-07-17 |
| Director, S2P Process, Controls & Analytics | Vertex Pharmaceuticals | Boston, United States | 2026-07-16 |
| Scientific Advisor, Director | IQVIA | Austin, United States | 2026-07-16 |
| Local Study Associate Director | IQVIA | Reading, United Kingdom | 2026-07-16 |
| Exec Director, Viral Vector Process Development | Gilead Sciences | United States | 2026-07-16 |
| Exec Director, API Synthetic Development | Neurocrine Biosciences | San Diego, United States | 2026-07-16 |
| General Manager | Eurofins Scientific | Littleton, United States | 2026-07-16 |
| Director | Eurofins Scientific | Bengaluru, India | 2026-07-16 |
| Director, Advanced Analytics | Grifols | United States | 2026-07-16 |
| MOP/Speaker Bureau Platform Operations Associate Director | Vertex Pharmaceuticals | Boston, United States | 2026-07-14 |
| Executive Director, Data & Methods (Data and Computational Sciences) | Vertex Pharmaceuticals | Boston, United States | 2026-07-14 |
| Senior Director, US Market Access Strategy, Povetacicept (POVE) | Vertex Pharmaceuticals | Boston, United States | 2026-07-14 |
| Associate Director Value and Access Consulting โ Sweden | IQVIA | Stockholm, Sweden | 2026-07-14 |